Golimumab Update


I just posted a blog which is a general update to research on Golimumab (sold as Simponi). There are three clinical trials underway right now:


Very interesting write-up, @joshualevy, thank you!

I would be very surprised if it was effective in any way for long-standing T1Ds, but who knows. The other two trials should be interesting!


I wonder what the long-term consequences of TNF-alpha inhibition could be. TNF-alpha is a pretty important factor in the immune system.


That exact issue came up the first time I blogged on Golimumab. Comment #3 in the list here:
describes the safety data we have so far.